X @The Economist

Novo Nordisk’s investors are rattled. The Danish drugmaker’s market value is down by two-thirds from its peak. Even so, Novo’s new chief executive is confident that it can recover https://t.co/yuDUuudB6Y https://t.co/A2bW1STvAf ...